MAPT and Alzheimer disease: For example, increasing the bioavailability of copper with compound Cu(II)(gtsm), which can remain at high level in the brain after uptake, could inhibit Aβ oligomers and tau phosphorylation while restoring cognitive function in APP/PS1 transgenic AD model mice.480,481